Literature DB >> 17664077

The expectorant activity of naringenin.

Bao-qin Lin1, Pei-bo Li, Yong-gang Wang, Wei Peng, Zhong Wu, Wei-wei Su, Hui Ji.   

Abstract

The expectorant activity of naringenin was studied. Mucus secretion was evaluated in mice by measuring the tracheal output of phenol red. Mucociliary movement function was investigated using a migration method of carbon granules in unanesthetized pigeons. And the effect of naringenin on the secretion of mucin and lysozyme was performed in the rat tracheal ring explants. Naringenin could significantly increase the secretion of phenol red from mouse tracheas at the doses of 30-67 mg/kg (i.g.) (P<0.05). Naringenin, at the dose of 90 mg/kg, increased the tracheal mucociliary velocity (TMV) to 144.4% of control (P<0.01). 100 microM naringenin could enhance the basal lysozyme secretion, but had no effect on the basal mucin secretion from the rat tracheal ring explants. Treatment with naringenin at higher concentration (10 micromol/l) could inhibit the 100 ng/ml lipopolysaccharide (LPS)-induced mucin increase. These data suggest, therefore, that naringenin has the expectorant activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664077     DOI: 10.1016/j.pupt.2007.05.001

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  10 in total

1.  Naringin Protects Ovalbumin-Induced Airway Inflammation in a Mouse Model of Asthma.

Authors:  Xiong Guihua; Liu Shuyin; Gao Jinliang; Shumin Wang
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

2.  Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits.

Authors:  Junli Lin; Jingjing Sun; Yandong Wang; Yan Ma; Wenpei Chen; Ziyang Zhang; Gang Gui; Baoqin Lin
Journal:  J Ocul Pharmacol Ther       Date:  2015-02       Impact factor: 2.671

3.  Expectorant and antitussive effect of Hedera helix and Rhizoma coptidis extracts mixture.

Authors:  Kee Jae Song; Young-June Shin; Kang Ro Lee; Eun Jung Lee; Yun Suk Suh; Kyung-Su Kim
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

4.  Antitussive, expectorant and analgesic effects of the ethanol seed extract of Picralima nitida (Stapf) Th. & H. Durand.

Authors:  Gabriel Dapaah; George Asumeng Koffuor; Priscilla Kolibea Mante; Inemesit Okon Ben
Journal:  Res Pharm Sci       Date:  2016 Mar-Apr

5.  Pharmacokinetic Comparisons of Naringenin and Naringenin-Nicotinamide Cocrystal in Rats by LC-MS/MS.

Authors:  Dan Xu; Gui-Qiu Zhang; Ting-Ting Zhang; Bo Jin; Chen Ma
Journal:  J Anal Methods Chem       Date:  2020-04-01       Impact factor: 2.193

Review 6.  Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology.

Authors:  Zhen Chen; Pan Chen; Hao Wu; Rui Shi; Weiwei Su; Yonggang Wang; Peibo Li
Journal:  Biomolecules       Date:  2020-12-08

7.  Inclusion of vitexin in β-cyclodextrin: preparation, characterization and expectorant/antitussive activities.

Authors:  Eliatania Clementino Costa; Pedro Modesto Nascimento Menezes; Ricardo Lúcio de Almeida; Fabrício Souza Silva; Luciano Augusto de Araújo Ribeiro; James Amalda da Silva; Ana Paula de Oliveira; Edigênia Cavalcante da Cruz Araújo; Larissa Araújo Rolim; Xirley Pereira Nunes
Journal:  Heliyon       Date:  2020-12-01

8.  In Vivo Evaluation of the Antiasthmatic, Antitussive, and Expectorant Activities and Chemical Components of Three Elaeagnus Leaves.

Authors:  Yuebin Ge; Fei Zhang; Qin Qin; Yingying Shang; Dingrong Wan
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-21       Impact factor: 2.629

9.  UFLC-Q-TOF-MS/MS-Based Screening and Identification of Flavonoids and Derived Metabolites in Human Urine after Oral Administration of Exocarpium Citri Grandis Extract.

Authors:  Xuan Zeng; Weiwei Su; Yuying Zheng; Hong Liu; Panlin Li; Weijian Zhang; Yuting Liang; Yang Bai; Wei Peng; Hongliang Yao
Journal:  Molecules       Date:  2018-04-12       Impact factor: 4.411

10.  Characterization, in Vitro and in Vivo Evaluation of Naringenin-Hydroxypropyl-ß-Cyclodextrin Inclusion for Pulmonary Delivery.

Authors:  Minyi Guan; Rui Shi; Yuying Zheng; Xuan Zeng; Weiyang Fan; Yonggang Wang; Weiwei Su
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.